https://adisinsight.springer.com/drugs/800066735?error=cookies_not_supported&code=cacea702-9f95-4d9a-a7f2-318198a6fe41
HIVV 104 - AdisInsight
HIVV 104 is a nucleic acid-based vaccine is being developed by Aegis Life (a spinout from Entos Pharmaceuticals) for the treatment of HIV infections. The
adisinsight